23
, -
.
, , ,
, .
.
.
: ( ,
) .
, .
, , ,
, -
,
. , -
:
, , .
, -
. -
50% ), -
( 1/3 ), - -
, -
. ,
,
, -
.
-
, -
. , -
, -
. ,
( , -
) .
,
, , . ,
W. . (1983),
. ,
90% . -
( 94%).
,
( , , ) , , -
, . ,
. ,
.
D. Lamb (1984) -
,
24
. ,
50% . -
( 10%
).
.
( )
.
, 5%
. -
,
.
“ ”. -
( ).
,
. -
.
, -
, ,
. -
: , .
,
,
. -
. “ ” “ ”,“ ” “ ”.
,
-
. ,
-
. , , -
, ,
,
, .
-
, , -
. -
, “ ” , -
, ,
,
-
.
.
: , -
.
, -
: , , -
25
. ,
.
-
.
, .
3
. -
,
. ,
, ,
. .
.
, , , ,
. -
.
, ,
, ,
,
, ( , , .).
, , -
.
-
. - -
, . -
.
. -
. -
, , , , -
, . -
.
, , ,
145-kDa, , -
, ,
), , -
.
,
Ki-67, ( , ).
. -
, -
.
2.2
2.2.1
. -
, , -
- . -
: ,
, , ( ), , -
( .5).
26
. -
, .
, , , -
.
carcinoma in situ ( - -
, , , ).
, , ,
. -
, ( . 4.3). -
, ,
, -.
“ ” “ ” ,
.
- - -
.
-
, , - .
( . 4.5) -
. , ,
.
,
. -
, .
( )
.
, , -
.
.
“ ” -
, .
, . ,
. ,
. :
, , , , -
. -
, .
2.2.2
.
-
. H. Ayabe et al. (1982) , -
. -
,
.
1.3 .
, -
( ) .
27
-
. -
[Nagano N.,1987].
, -
, . ( . 1.3).
2.2.3
, . -
. -
. -
.
.
, ( ,
, ).
2.2.4 ( , , ) -
-
.
, -
, -
. , -
.
“ ” . , -
.
1905 . . -
-
, -
.
, .
M.Letulle 1924 . . (1941) -
. -
-
R.Rossle (1949).
(1947) -
. -
.
“
” .
-
. -
, -
. -
per continuitatem ,
. -
28
-
( ., 1957; Eck H.,1957).
(1962). 1963 . S.Grohme 66 -
. 18 -
. S.Grohme ,
. -
. , -
.
S. Battaglia (1953) -
. -
“ ” ( -
. , -
-
.
.
Rosle (1949) S. Grohme (1963) , -
-
. -
, -
.
-
( ,
( ., 1959).
(1966) , -
.
-
. 36 (69%) 45 . 6-7
, 12-64 .
.
-
.
, “ ” -
. , -
.
(1966) ,
, -
. -
. -
( -
, .).
-
, . -
. -
, ,
29
“ ” -
[ ., ., 1994].
2.3 ( ) 2.3.1
-
. , -
. , , -
. -
( , “ ” ). -
,
. -
,
, . .
.
, -
,
.
. . -
. -
, .
-
, , -
, -
. ,
.
.
-
.
-
. . -
, .
,
. -
.
. -
.
, ,
( . .6).
-
,
.
2.3TNM
-
. -
30
.
. -
. , -
, . -
“ ” -
.
, -
.
( -
), -
. ,
( ): I - -
; II - -
; III - ,
; IV - .
. , , -
. -
III . , -
. -
.
163 -
.
.
-
TNM 1986 .
. -
, (
). , -
, . -
(174 ) 1 48% , 5 - 24,8%. 85 80,3% [Gelder C.M., Hetzel M.R.,1993]. ( .
4.5.2 5.5).
-
( . 1.5).
( . , ). -
C.M.Gelder (1993) 54 174 -
, 24 - , 76 - , 13 -
. (
, ) pTNM: pT, pN, pM.
TNM
-
IS - (carcinoma in situ). T0 - .
1 - 3 -
.
2 - 3
.
31
3 - ,
.
4 - , .
N -
N0 - ( -
, ).
N1 - .
N2 - -
.
N3 -
( ,
.
-
0 - .1 - .
1 -
: |
|
|
|
|
PUL |
|
MAR |
|
OSS |
|
PLE |
|
HEP |
|
PER |
|
BRA |
|
SKI |
|
LYM |
|
OTH |
(R- )
-
R.
.
R0 -
R1 -
R2 -
|
|
|
|
0 |
TIS |
- |
- |
I |
T1 |
N0 |
M0 |
|
T2 |
N0 |
M0 |
II |
T1 -2 |
N1 |
M0 |
IIIa |
T3 |
N0 |
M0 |
|
T3 |
N1 |
M0 |
|
T1-3 |
N2 |
M0 |
IIIb |
T1-4 |
N3 |
M0 |
|
T4 |
N0-3 |
M0 |
IV |
T1-4 |
N0-3 |
M1 |
, .
, . I- IIIa . , IIIb IV -
32
, ,
). -
,
.
. -
( .4).
4.
TNM |
|
|
|
|
|
|
5 ( |
|
- |
|
|
%) |
|
( ) |
T1N0M0 |
6 |
|
|
|
T2N0M0 |
|
|
|
|
T1N1M0 |
|
|
|
|
T2N1M0 |
|
|
|
|
T3N0M0 |
|
|
|
|
T3N1M0 |
|
|
|
|
T1-3N2M0-1 |
|
|
|
|
3. |
||||
|
. |
,
. ,
, . -
, , -
, .
, -
-
.
, -
-
.
-
-
.
-
-
. -
. -
; ,
; .
3.1.
-
,
. -,
.